UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037532
Receipt number R000042788
Scientific Title Research of diagnostic significance of lymph nodes micrometastasis by OSNA for pStage II colorectal cancer.
Date of disclosure of the study information 2019/08/01
Last modified on 2022/08/01 13:19:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research of diagnostic significance of lymph nodes micrometastasis by OSNA for pStage II colorectal cancer.

Acronym

Research of diagnostic significance of lymph nodes micrometastasis by OSNA for pStage II colorectal cancer.

Scientific Title

Research of diagnostic significance of lymph nodes micrometastasis by OSNA for pStage II colorectal cancer.

Scientific Title:Acronym

Research of diagnostic significance of lymph nodes micrometastasis by OSNA for pStage II colorectal cancer.

Region

Japan


Condition

Condition

Colorectal Cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To pick up high risk cases of Stage II colorectal cancer using lymph nodes metastasis detected by OSNA and to clarify the necessity of postoperative chemotherapy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

3 year recurrence free survival rate

Key secondary outcomes

5 year recurrence free survival rate
Association between clinicopathological factors and diagnosis of OSNA
Association with postoperative adjuvant chemotherapy


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

79 years-old >=

Gender

Male and Female

Key inclusion criteria

<OSNA installed facility>
Patients 20 years old or older
Patients diagnosed with cStage I-III colorectal cancer
Patients who is to carry out OSNA
Patients who have not offered a refuse to optout

<OSNA non-installed facility>
Patients 20 years old or older
Patients diagnosed with cStage I-III colorectal cancer
Lymph nodes collected at the time of surgery is cryopreserved and available
Patients who obtained written consent

Key exclusion criteria

<OSNA installed facility>
Patients who lack the ability to agree
Patients who receive neoadjuvant chemotherapy
Active double cancer (synchronous double cancer/Multiple cancer and metachronous double cancer/multiple cancer with disease-free survival of 5 years or less, but excluding carcinoma in situ that is judged to be cured by local treatment
Patients who died or relapsed within 60 days after the operation
Patients who is judged to be ineligible to participate in the study by the research principal doctor or co-investigator

<OSNA non-installed facility>
Patients who lack the ability to agree
Patients who receive neoadjuvant chemotherapy
Active double cancer (synchronous double cancer/Multiple cancer and metachronous double cancer/multiple cancer with disease-free survival of 5 years or less, but excluding carcinoma in situ that is judged to be cured by local treatment
Patients who died or relapsed within 60 days after the operation
Patients who is judged to be ineligible to participate in the study by the research principal doctor or co-investigator

Target sample size

3000


Research contact person

Name of lead principal investigator

1st name Nariaki
Middle name
Last name Matsuura

Organization

Osaka International Cancer Institute

Division name

Gastroenterological surgery

Zip code

5418567

Address

3-1-69 Otemae, Chuoku, Osaka

TEL

0669451181

Email

nmatsuura@mc.pref.osaka.jp


Public contact

Name of contact person

1st name Mamoru
Middle name
Last name Uemura

Organization

Osaka University

Division name

Department of Gastroenterology

Zip code

5650871

Address

2-2 Yamadaoka, Suita, Osaka

TEL

0668793251

Homepage URL


Email

muemura@gesurg.med.osaka-u.ac.jp


Sponsor or person

Institute

Osaka International Institute

Institute

Department

Personal name



Funding Source

Organization

BTC Research

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka University Clinical Research Review Committee

Address

2-2 Yamadaoka, Suita, Osaka

Tel

0662108289

Email

rinri@hp-crc.med.osaka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 05 Month 13 Day

Date of IRB

2019 Year 05 Month 14 Day

Anticipated trial start date

2019 Year 05 Month 14 Day

Last follow-up date

2023 Year 06 Month 30 Day

Date of closure to data entry

2026 Year 06 Month 30 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2019 Year 07 Month 29 Day

Last modified on

2022 Year 08 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042788


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name